| Literature DB >> 34679092 |
Lauren A Fowler1,2, Audrey D Powers1, Michael B Williams1, James L Davis3, Robert J Barry1, Louis R D'Abramo1, Stephen A Watts1,2.
Abstract
The effects of saturated fat intake on obesity and cardiovascular health remain inconclusive, likely due in part to their varied nature and interactions with other nutrients. Investigating the synergistic effects of different saturated fat sources with other dietary lipid components will help establish more accurate nutritional guidelines for dietary fat intake. Over the past two decades, zebrafish (Danio rerio) have been established as an attractive model system to address questions regarding contributions of dietary lipid intake to diet-induced obesity in humans. The goal of the present study was to assess interactions of three different saturated fat sources (milk fat, palm oil, and coconut oil) with sex and total dietary lipid intake on weight gain and body composition in adult zebrafish. Larvae were raised on live feeds until 28 days post fertilization, and then fed a formulated maintenance diet until three months of age. An eight-week feeding trial was then initiated, in which zebrafish were fed nine experimental low- and high-fat diets varying in saturated fatty acid and long-chain polyunsaturated fatty acid content, in addition to a low-fat and high-fat control diet. At termination of the feeding trial, each treatment was evaluated according to body mass, moisture content, and adiposity. Sex and diet significantly interacted in their effects on body mass (P = 0.026), moisture content (P = 0.044), and adiposity (P = 0.035). The influence of saturated fat source on body mass was observed to be dependent on intake of total dietary lipid. In females, all three saturated fat sources had similar effects on adiposity. From these observations, we hypothesize that impacts of saturated fat intake on energy allocation and obesity-related phenotypes are influenced by both sex and intake of other dietary lipid components. Our results suggest that current nutritional guidelines for saturated fat intake may need to be re-evaluated and take sex-specific recommendations into consideration.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34679092 PMCID: PMC8535427 DOI: 10.1371/journal.pone.0257914
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Composition of reference and experimental diets (as fed).
| Reference diets | Experimental diets | ||||
|---|---|---|---|---|---|
| Low-fat | High-fat | Low-fat | High-fat 1 | High-fat 2 | |
|
| |||||
| Saturated fat source | - | - | 1.50 | 8.10 | 14.63 |
| Safflower oil | 2.10 | 10.80 | 1.05 | 5.40 | 1.05 |
| Menhaden fish oil | 1.05 | 5.40 | 0.52 | 2.70 | 0.52 |
| Alpha cellulose | 16.04 | 2.99 | 18.96 | 2.99 | 2.99 |
| Casein-vita free | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 |
| Fish protein hydrosylate | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 |
| Soy protein isolate | 6.60 | 6.60 | 6.60 | 6.60 | 6.60 |
| Wheat starch | 9.34 | 9.34 | 9.34 | 9.34 | 9.34 |
| Dextrin | 2.16 | 2.16 | 2.16 | 2.16 | 2.16 |
| Alginate | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Soy lecithin (refined) | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Vitamin mix | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Mineral mix BTm | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
| Canthaxanthin (10%) | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| K phosphate monobasic | 1.15 | 1.15 | 1.15 | 1.15 | 1.15 |
| Glucosamine | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Betaine | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 |
| Cholesterol | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
| Ascorbylpalmitate | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
|
| |||||
| Lipid (%) | 9.09 | 22.14 | 9.09 | 22.14 | 22.14 |
| Protein (%) | 49.82 | 49.82 | 49.82 | 49.82 | 49.82 |
| Carbohydrate (%) | 12.16 | 12.16 | 12.16 | 12.16 | 12.16 |
| Energy (cal/g) | 4160 | 5393 | 4160 | 5393 | 5393 |
a Palm fruit oil, coconut oil, or anhydrous milk fat.
bSigma-Aldrich, Cat no. S8281.
cVirginia Prime Gold, Omega Protein.
dComposition of MP Vitamin Diet Fortification Mixture (%): p-aminobenzoic acid, 0.500; ascorbic acid, 4.500; biotin, 0.002; calcium pantothenate, 0.300; choline chloride, 7.500; DL-α-tocopherol acetate, 2.200; folic acid, 0.009; inositol, 0.5; menadione, 0.225; niacin, 0.425; pyridoxine hydrochloride, 0.100; riboflavin, 0.100; thiamine hydrochloride, 0.100; vitamin A acetate (500,000 IU/gm), 0.180; vitamin B12, 0.000135; vitamin D2 (850,000 IU/gm), 0.0125.
eComposition of the mineral premix (%): calcium carbonate, 2.100; calcium phosphate dibasic, 73.500; citric acid, 0.227; cupric citrate, 0.046; ferric citrate, 0.558; magnesium oxide, 2.500; magnesium citrate, 0.835; potassium iodide, 0.001; potassium phosphate dibasic, 8.100; potassium sulfate, 6.800; sodium chloride, 3.060; sodium phosphate, 2.140; zinc citrate, 0.133.
Fig 1Comparison of dietary treatments by energy content and saturated fat source.
Estimated fatty acid content of primary lipid sources.
| Fatty acid content | SAF | MFO | CO | PFO | AMF |
|---|---|---|---|---|---|
|
| |||||
| C08:0 Octanoic (Caprylic) | - | - | 8.0% | - | 1.0% |
| C10:0 Decanoic (Capric) | - | - | 6.4% | - | 2.0% |
| C12:0 Dodecanoic (Lauric) | - | - | 48.5% | 0.2% | 3.1% |
| C14:0 Tetradecanoic (Myristic) | 0.1% | 8.04% | 18.0% | 1.1% | 11.7% |
| C16:0 Hexadecanoic (Palmitic) | 6.0–7.5% | 16.85% | 8.0% | 44.0% | 26.2% |
| C18:0 Octadecanoic (Stearic) | 2.0–2.5% | 3.09% | 2.5% | 4.5% | 12.5% |
| C20:0 Eicosanoic (Arachidic) | 0.5% | - | - | 0.1% | - |
| C22:0 Docosanoic | - | - | - | - | - |
| C24:0 Tetracosanoic | - | - | - | - | - |
| Σ Saturated fatty acid content | 9% | 29% | 91.6% | 49.8% | 65.0% |
|
| |||||
| C14:1 Tetradecenoic (Myristoleic) | - | - | - | - | - |
| C16:1 Hexadecenoic (Palmitoleic) | 0.1% | 11.50% | - | - | 1.9% |
| C18:1n-9 Octadecenoic (Oleic) | 12.0% | 9.74% | 6.5% | 39.2% | 28.2% |
| C20:1n-9 Eicosenoic (Gadoleic) | 0.3% | - | - | - | - |
| C22:1n-9 Docosenoic (Erucic) | - | - | - | - | - |
| C24:1n-9 Tetracosenoic (Nervonic) | - | - | - | - | - |
| Σ Monounsaturated fatty acid content | 13% | 21.3% | 6.5% | 40% | 31.0% |
|
| |||||
| C18:2n-6 Octadecadienoic (Linoleic) | 70.0% | 1.89% | 1.5% | 10.1% | 2.9% |
| C18:3n-6 Octadecatrienoic (GLA) | - | - | - | - | - |
| C20:2n-6 Eicosadienoic | - | - | - | - | - |
| C20:3n-6 Eicosatrienoic (DGLA) | - | - | - | - | - |
| C20:4n-6 Eicosatetraenoic (Arachidonic) | - | - | - | - | - |
| C22:2n-6 Docosadienoic | - | - | - | - | - |
| C22:4n-6 Docosatetraenoic (Adrenic) | - | - | - | - | - |
| C22:5n-6 Docosapentaenoic (Osbond) | - | - | - | - | - |
| Σ n-6 fatty acid content | 72.0% | 5.30% | 1.8% | 10.3% | 3.0% |
|
| |||||
| C18:3n-3 Octadecatrienoic (α- Linolenic) | 3.3% | 2.20% | - | 0.4% | 0.5% |
| C18:4n-3 Octadecatetranoic (Stearidonic) | - | 3.21% | - | - | - |
| C20:3n-3 Eicosatrienoic | - | - | - | - | - |
| C20:4n-3 Eicosatetraenoic | - | 2.49% | - | - | - |
| C20:5n-3 Eicosapentaenoic (EPA) | - | 14.05% | - | - | - |
| C21:5n-3 Heneicosapentaeonic | - | - | - | - | - |
| C22:3n-3 Docosatrienoic | - | - | - | - | - |
| C22:5n-3 Docosapentaenoic | - | 2.95% | - | - | - |
| C22:6n-3 Docosahexaenoic (DHA) | - | 12.26% | - | - | - |
| Σ n-3 fatty acid content | 3.6% | 36.65% | <1% | 0.4% | 0.5% |
Abbreviations: AMF, anhydrous milk fat; CO, coconut oil; MFO, menhaden fish oil; PFO, palm fruit oil; SAF, safflower oil.
aSigma-Aldrich, Cat nos. S8281 (safflower oil), C1758 (coconut oil), and W530216 (palm fruit oil).
bVirginia Prime Gold, Omega Protein.
cEnvigo Teklad Diets, Product Code CA.0366.
Composition of maintenance (grow-out) diet.
| Ingredient | Amount (g/100 g) |
|---|---|
| Safflower oil | 2.33 |
| Menhaden fish oil | 4.67 |
| Alpha cellulose | 1.00 |
| Casein-vita free | 25.00 |
| Fish protein hydrosylate | 20.00 |
| Soy protein isolate | 5.00 |
| Wheat gluten | 7.00 |
| Wheat starch | 9.60 |
| Dextrin | 5.00 |
| Alginate (TIC algin 400) | 5.38 |
| Soy lecithin (refined) | 4.00 |
| Vitamin mix | 4.00 |
| Mineral mix BTm | 3.00 |
| Canthaxanthin (10%) | 2.31 |
| Potassium phosphate monobasic | 1.15 |
| Glucosamine | 0.25 |
| Betaine | 0.15 |
| Cholesterol | 0.12 |
| Ascorbylpalmitate | 0.04 |
aSigma-Aldrich, Cat no. S8281.
bVirginia Prime Gold, Omega Protein.
cComposition of MP Biomedicals Vitamin Diet Fortification Mixture (%): p-aminobenzoic acid, 0.500; ascorbic acid, 4.500; biotin, 0.002; calcium pantothenate, 0.300; choline chloride, 7.500; DL-α-tocopherol acetate, 2.200; folic acid, 0.009; inositol, 0.5; menadione, 0.225; niacin, 0.425; pyridoxine hydrochloride, 0.100; riboflavin, 0.100; thiamine hydrochloride, 0.100; vitamin A acetate (500,000 IU/gm), 0.180; vitamin B12, 0.000135; vitamin D2 (850,000 IU/gm), 0.0125.
dComposition of the mineral premix (%): calcium carbonate, 2.100; calcium phosphate dibasic, 73.500; citric acid, 0.227; cupric citrate, 0.046; ferric citrate, 0.558; magnesium oxide, 2.500; magnesium citrate, 0.835; potassium iodide, 0.001; potassium phosphate dibasic, 8.100; potassium sulfate, 6.800; sodium chloride, 3.060; sodium phosphate, 2.140; zinc citrate, 0.133.
Sample sizes by treatment and sex.
| Body mass | Moisture content | Total body lipid | ||||
|---|---|---|---|---|---|---|
| M | F | M | F | M | F | |
|
| ||||||
| Low | 95 | 91 | 24 | 24 | 24 | 24 |
| High | 83 | 96 | 24 | 23 | 24 | 24 |
|
| ||||||
| Low | 93 | 90 | 25 | 26 | 24 | 24 |
| High | 102 | 90 | 24 | 25 | 24 | 24 |
| High | 101 | 89 | 24 | 25 | 23 | 24 |
|
| ||||||
| Low | 87 | 105 | 25 | 25 | 23 | 23 |
| High | 93 | 97 | 24 | 23 | 24 | 23 |
| High | 91 | 98 | 24 | 26 | 24 | 24 |
|
| ||||||
| Low | 84 | 107 | 24 | 24 | 24 | 24 |
| High | 88 | 89 | 25 | 25 | 24 | 24 |
| High | 92 | 92 | 26 | 25 | 24 | 24 |
Diet comparison groups for planned pairwise comparisons.
| Comparison group | Diets included |
|---|---|
| One | All low-fat diets (Reference, coconut, palm, and milk fat) |
| Two | High-fat reference and high-fat 2 diets (coconut, palm, and milk fat) |
| Three | Coconut oil diets (low-fat, high-fat 1, and high-fat 2) |
| Four | Palm oil diets (low-fat, high-fat 1, and high-fat 2) |
| Five | Milk fat diets (low-fat, high-fat 1, and high-fat 2) |
Main and interactive effects of diet, sex, and cohort on wet body mass.
| Model | Fixed effect | Sum of squares | df | Mean squares | F-statistic | Pr(>F) |
|---|---|---|---|---|---|---|
|
| Diet | 2.468 | 10 | 0.247 | 4.680 | <0.001 |
| Sex | 40.320 | 1 | 40.320 | 764.209 | <0.001 | |
| Cohort | 22.950 | 1 | 22.950 | 435.040 | <0.001 | |
| Diet*sex | 1.078 | 10 | 0.108 | 2.040 | 0.026 | |
|
| Diet | 0.707 | 10 | 0.071 | 3.742 | <0.001 |
| Cohort | 3.955 | 1 | 3.955 | 209.164 | <0.001 | |
| Diet*cohort | 0.410 | 10 | 0.746 | 0.746 | 0.680 | |
|
| Diet | 2.460 | 10 | 0.246 | 3.660 | <0.001 |
| Cohort | 24.448 | 1 | 24.448 | 363.580 | <0.001 | |
| Diet*cohort | 1.286 | 10 | 0.129 | 1.910 | 0.051 |
aLog-transformed for analysis.
bAnalyzed with mixed effects models, which controlled for tank as a random effect.
Fig 2Comparison of mean wet body mass among low-fat, high-fat 2, and reference diet groups in male and female zebrafish.
Error bars represent standard error of the mean. Different letters indicate between-group differences at P<0.05. LFREF = low-fat reference; LFC = low-fat coconut; LFP = low-fat palm; LFMF = low-fat milk fat; HFREF = high-fat reference; HFC2 = high-fat coconut 2; HFP2 = high-fat palm 2; HFMF2 = high-fat milk fat 2.
Fig 3Comparison of mean wet body mass among diet groups within each saturated fat source in male and female zebrafish.
Error bars represent standard error of the mean. Different letters indicate between-group differences at P<0.05. LFC = low-fat coconut; HFC1 = high-fat coconut 1; HFC2 = high-fat coconut 2; LFP = low-fat palm; HFP1 = high-fat palm 1; HFP2 = high-fat palm 2; LFMF = low-fat milk fat; HFMF1 = high-fat milk fat 1; HFMF2 = high-fat milk fat 2.
Fig 4Comparison of mean lipid content (adiposity) among low-fat, high-fat 2, and reference diet groups in male and female zebrafish.
Error bars represent standard error of the mean. Different letters indicate between-group differences at P<0.05. LFREF = low-fat reference; LFC = low-fat coconut; LFP = low-fat palm; LFMF = low-fat milk fat; HFREF = high-fat reference; HFC2 = high-fat coconut 2; HFP2 = high-fat palm 2; HFMF2 = high-fat milk fat 2.
Fig 5Comparison of mean lipid content (adiposity) among diet groups within each saturated fat source in male and female zebrafish.
Error bars represent standard error of the mean. Different letters indicate between-group differences at P<0.05. LFC = low-fat coconut; HFC1 = high-fat coconut 1; HFC2 = high-fat coconut 2; LFP = low-fat palm; HFP1 = high-fat palm 1; HFP2 = high-fat palm 2; LFMF = low-fat milk fat; HFMF1 = high-fat milk fat 1; HFMF2 = high-fat milk fat 2.
Main and interactive effects of diet, sex, and cohort on moisture content.
| Model | Fixed effects | Sum of squares | df | Mean squares | F-statistic | Pr(>F) |
|---|---|---|---|---|---|---|
|
| Diet | 0.019 | 10 | 0.002 | 2.818 | 0.004 |
| Sex | 0.042 | 1 | 0.042 | 6.405 | 0.228 | |
| Cohort | 0.009 | 1 | 0.009 | 13.577 | 0.003 | |
| Diet*sex | 0.009 | 10 | 0.001 | 1.315 | 0.044 | |
|
| Diet | 0.007 | 10 | 0.001 | 1.559 | 0.139 |
| Cohort | 0.003 | 1 | 0.003 | 7.583 | 0.018 | |
| Diet*cohort | 0.004 | 10 | 0.0003 | 0.887 | 0.549 | |
|
| Diet | 0.017 | 10 | 0.002 | 1.977 | 0.042 |
| Cohort | 0.008 | 1 | 0.008 | 9.609 | 0.008 | |
| Diet*cohort | 0.002 | 10 | 0.0002 | 0.198 | 0.996 |
aLog-transformed for analysis.
bAnalyzed with mixed effects models, which controlled for tank as a random effect.
Fig 6Comparison of mean carcass moisture content among low-fat, high-fat 2, and reference diet groups in male and female zebrafish.
Error bars represent standard error of the mean. Different letters indicate between-group differences at P<0.05. LFREF = low-fat reference; LFC = low-fat coconut; LFP = low-fat palm; LFMF = low-fat milk fat; HFREF = high-fat reference; HFC2 = high-fat coconut 2; HFP2 = high-fat palm 2; HFMF2 = high-fat milk fat 2.
Fig 7Comparison of mean carcass moisture content among diet groups within each saturated fat source in male and female zebrafish.
Error bars represent standard error of the mean. Different letters indicate between-group differences at P<0.05. LFC = low-fat coconut; HFC1 = high-fat coconut 1; HFC2 = high-fat coconut 2; LFP = low-fat palm; HFP1 = high-fat palm 1; HFP2 = high-fat palm 2; LFMF = low-fat milk fat; HFMF1 = high-fat milk fat 1; HFMF2 = high-fat milk fat 2.
Main and interactive effects of diet, sex, and cohort on adiposity/lipid content.
| Model | Fixed effects | Sum of squares | df | Mean squares | F-statistic | Pr(>F) |
|---|---|---|---|---|---|---|
|
| Diet | 2.802 | 10 | 0.280 | 10.068 | <0.001 |
| Sex | 2.471 | 1 | 2.470 | 88.740 | <0.001 | |
| Cohort | 0.076 | 1 | 0.076 | 2.734 | 0.131 | |
| Diet*sex | 0.548 | 10 | 0.055 | 1.971 | 0.035 | |
|
| Diet | 1.053 | 10 | 0.105 | 4.232 | <0.001 |
| Cohort | 0.005 | 1 | 0.005 | 0.212 | 0.645 | |
| Diet*cohort | 0.268 | 10 | 0.027 | 1.080 | 0.378 | |
|
| Diet | 1.912 | 10 | 0.191 | 6.871 | <0.001 |
| Cohort | 0.035 | 1 | 0.035 | 1.256 | 0.287 | |
| Diet*cohort | 0.241 | 10 | 0.024 | 0.866 | 0.569 |
aLog-transformed for analysis.
bAnalyzed with mixed effects models, which controlled for tank as a random effect.